Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.110
-0.090 (-4.09%)
Nov 21, 2024, 3:46 PM EST - Market closed

Edesa Biotech Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 2018 - 2017
Net Income
-6.93-8.37-17.55-13.34-6.36-3.14
Upgrade
Depreciation & Amortization
0.190.180.120.120.060.01
Upgrade
Stock-Based Compensation
0.961.252.263.20.60.05
Upgrade
Change in Accounts Receivable
-0.510.562.03-3.230.130.01
Upgrade
Change in Inventory
-----0.08
Upgrade
Change in Accounts Payable
0.85-0.560.88-0.121-1.92
Upgrade
Change in Other Net Operating Assets
0.070.3-0.02-0.28-0.4-0.31
Upgrade
Operating Cash Flow
-5.39-6.64-12.28-13.66-4.99-5.23
Upgrade
Capital Expenditures
---0.01-0.01-0-0.01
Upgrade
Sale of Property, Plant & Equipment
----0.050.04
Upgrade
Cash Acquisitions
-----6.39
Upgrade
Sale (Purchase) of Intangibles
-----0.03-
Upgrade
Investing Cash Flow
---0.01-0.010.026.42
Upgrade
Long-Term Debt Issued
----0.03-
Upgrade
Total Debt Issued
----0.03-
Upgrade
Net Debt Issued (Repaid)
-0.03---0.03-
Upgrade
Issuance of Common Stock
1.215.1211.9614.367.6-
Upgrade
Other Financing Activities
-0.15-0.29-0.33-0.19-0.53-
Upgrade
Financing Cash Flow
1.044.8311.6314.177.09-
Upgrade
Foreign Exchange Rate Adjustments
-0.060.08-0.090.120.060.11
Upgrade
Net Cash Flow
-4.42-1.73-0.750.632.181.3
Upgrade
Free Cash Flow
-5.39-6.64-12.28-13.67-4.99-5.24
Upgrade
Free Cash Flow Margin
-----1518.00%-1274.42%
Upgrade
Free Cash Flow Per Share
-1.72-2.32-5.86-7.92-4.06-7.99
Upgrade
Levered Free Cash Flow
-3.77-3.78-6.12-14.93-2.66-
Upgrade
Unlevered Free Cash Flow
-3.77-3.78-6.12-14.93-2.66-
Upgrade
Change in Net Working Capital
-0.32-0.55-2.993.44-0.72-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.